OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Statement re. Government press release
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the press release issued this afternoon by the UK Government announcing its partnership with British rapid test manufacturers.
Further to the RNS announcement released by Omega this morning at 7am, the Company is named as one of two British companies to have secured contracts with the Government to supply rapid lateral flow tests.
Quote in the press release Colin King, CEO of Omega Diagnostics Group plc, said:
"We are delighted to deploy our state-of-the-art lateral flow test production facilities in support of the UK government's COVID-19 testing programme. The collaboration with other UK-based IVD companies and DHSC has facilitated the rapid development and manufacturing capability within the UK. We particularly welcome the government's assistance to secure the specialist machinery needed to dramatically increase the scale of our manufacturing capacity which has allowed us to ensure a ready supply of high quality, reliable British made rapid lateral flow tests.
"Rapid lateral flow tests are an essential tool for identifying COVID-19 cases where people have no visible symptoms but could still be infectious and continue to spread the virus. We are very proud to be playing our part in the nation's effort to control the spread of coronavirus by using our production facilities in Scotland."
The full text of the press release can be seen here:
The following press release was also released in Scotland:
https://www.gov.uk/government/news/uk-government-to-partner-with-clackmannanshire-test-manufacturer
Contacts:
| Omega Diagnostics Group PLC | |
| Colin King, Chief Executive | via Walbrook PR |
| Kieron Harbinson, Group Finance Director | |
| | |
| finnCap Ltd | Tel: 020 7220 0500 |
| Geoff Nash/Edward Whiley (Corporate Finance) | |
| Alice Lane (ECM) | |
| | |
| Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
| Paul McManus | Mob: 07980 541 893 |
| Lianne Cawthorne | Mob: 07584 391 303 |
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
